A2A at BiopharmaA2A PharmaMay 16, 20191 min readUpdated: Feb 7, 2020A2A participated at the AI Applications Summit Biopharma discussing the urgency to advance AI applications in industry to bring benefits to patients fasterLEARN MORE
A2A participated at the AI Applications Summit Biopharma discussing the urgency to advance AI applications in industry to bring benefits to patients fasterLEARN MORE
A2A co-founded biomea Fusion raises $56MBiomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations...
A2A / Daewoong Pharmaceutical Oncology Agreement A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology...
Comments